Short answer
Tyra Biosciences, Inc. (TYRA) filed an 8-K current report with the SEC on May 13, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q1 2026 results for quarter ended March 31, 2026 announced May 13, 2026.
Tyra Biosciences, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 results for quarter ended March 31, 2026 announced May 13, 2026
- Financial details and management commentary contained in Exhibit 99.1 press release
- Disclosure furnished under Regulation FD, limiting Section 18 Exchange Act liability
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Tyra Biosciences, Inc. 8-K filings
Get the next TYRA 8-K as it lands
Follow TYRA for push alerts, or ask the research agent what this filing means.